Extract

The objective of the current study is to investigate the safety and efficacy of BI 10773 in 2 different doses compared to Metformin or to Sitagliptin given for 78 weeks in different modalities of treatment in patients with type 2 diabetes mellitus.

Inclusion criteria

• Diabetes Mellitus, Type 2

Country

• Austria
• Croatia
• Czech Republic
• Estonia
• Finland
• France
• Germany
• Hungary
• Italy
• Korea, Republic of
• Latvia
• Lithuania
• Norway
• Romania
• Russian Federation
• Slovakia
• Spain
• Sweden
• Taiwan, Province of China
• Ukraine
• United States

Links

• nct
• ictrp